EP Patent
EP3412678B1 — Macrocyclic polymorphs, compositions comprising such polymorphs, and methods of use and manufacture thereof
Assigned to Organon Pharma UK Ltd · Expires 2020-08-19 · 6y expired
What this patent protects
Patent listed against Dificid.
Drugs covered by this patent
- Dificid (FIDAXOMICIN) · Cubist Pharms Llc
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.